AZATHIOPRINE

AZATHIOPRINE was reported 88911 times

AZATHIOPRINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYNOVIAL FLUID ANALYSIS 79 0.9080
1 GRIP STRENGTH 119 0.5197
2 HEPATOSPLENIC T-CELL LYMPHOMA 155 0.4178
3 PULMONARY VASCULITIS 222 0.4126
4 BLOOD IRON ABNORMAL 359 0.3675
5 LUPUS VULGARIS 457 0.3627
6 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 240 0.3593
7 TOTAL LUNG CAPACITY ABNORMAL 135 0.3470
8 SLE ARTHRITIS 84 0.2958
9 RETINITIS 508 0.2938
10 CAPILLARITIS 81 0.2935
11 ILEOCAECAL RESECTION 94 0.2733
12 ELBOW DEFORMITY 88 0.2543
13 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 108 0.2353
14 BONE EROSION 827 0.2336
15 CHOLESTASIS OF PREGNANCY 106 0.2304
16 SERONEGATIVE ARTHRITIS 264 0.2304
17 OVERLAP SYNDROME 161 0.2300
18 NODULAR REGENERATIVE HYPERPLASIA 144 0.2243
19 SPIROMETRY ABNORMAL 134 0.2241
20 GRANULOMA SKIN 181 0.2205
21 DEEP VEIN THROMBOSIS POSTOPERATIVE 425 0.2122
22 FACET JOINT SYNDROME 679 0.2083
23 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 431 0.2078
24 RHEUMATIC FEVER 908 0.2035
25 DISLOCATION OF VERTEBRA 445 0.1949
26 MITE ALLERGY 127 0.1939
27 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 132 0.1801
28 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 332 0.1627
29 X-RAY ABNORMAL 290 0.1620
30 CLEAR CELL RENAL CELL CARCINOMA 111 0.1595
31 TENOSYNOVITIS STENOSANS 88 0.1580
32 TERMINAL ILEITIS 96 0.1564
33 ILEAL STENOSIS 277 0.1557
34 MYCOTIC ALLERGY 128 0.1497
35 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1060 0.1478
36 SWOLLEN JOINT COUNT INCREASED 458 0.1435
37 C-REACTIVE PROTEIN ABNORMAL 921 0.1434
38 LUNG TRANSPLANT REJECTION 93 0.1409
39 RHEUMATOID FACTOR POSITIVE 804 0.1391
40 NEURITIS 213 0.1379
41 DUODENAL ULCER PERFORATION 1001 0.1345
42 PERIPHERAL VENOUS DISEASE 541 0.1323
43 DRUG TOLERANCE DECREASED 371 0.1320
44 DUST ALLERGY 127 0.1295
45 BLOOD PARATHYROID HORMONE DECREASED 190 0.1281
46 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 75 0.1269
47 FAECAL CALPROTECTIN INCREASED 400 0.1262
48 LUPUS NEPHRITIS 228 0.1218
49 ONYCHOMADESIS 498 0.1185
50 GRANULOMATOSIS WITH POLYANGIITIS 141 0.1168
51 INTESTINAL STENOSIS 490 0.1161
52 CUSHINGOID 354 0.1102
53 RHEUMATOID NODULE 303 0.1099
54 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 557 0.1093
55 BREAST CANCER STAGE III 690 0.1064
56 C-REACTIVE PROTEIN 98 0.1057
57 CONJUNCTIVITIS ALLERGIC 155 0.1046
58 PEMPHIGUS 1288 0.1029
59 ANAL FISTULA 540 0.1011
60 CHRONIC ALLOGRAFT NEPHROPATHY 79 0.1009
61 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 231 0.1002
62 HELICOBACTER INFECTION 1024 0.0995
63 SMALL INTESTINAL STENOSIS 106 0.0995
64 HYPERCHOLESTEROLAEMIA 959 0.0992
65 SYNOVITIS 1789 0.0991
66 LARGE INTESTINAL STENOSIS 196 0.0980
67 HAND DEFORMITY 1283 0.0977
68 INTESTINAL FISTULA 137 0.0972
69 SCLERITIS 155 0.0967
70 ONYCHOMYCOSIS 423 0.0963
71 MUSCLE INJURY 797 0.0961
72 PANNICULITIS 232 0.0958
73 DRUG LEVEL BELOW THERAPEUTIC 512 0.0927
74 GRIP STRENGTH DECREASED 814 0.0924
75 PORPHYRIA ACUTE 132 0.0920
76 ENTEROCUTANEOUS FISTULA 81 0.0918
77 FISTULA DISCHARGE 114 0.0903
78 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 159 0.0899
79 FOLLICULITIS 938 0.0894
80 RED BLOOD CELL SEDIMENTATION RATE INCREASED 980 0.0885
81 RESPIRATORY SYMPTOM 249 0.0875
82 CYTOMEGALOVIRUS COLITIS 200 0.0869
83 JC VIRUS INFECTION 138 0.0862
84 LUPUS-LIKE SYNDROME 749 0.0825
85 HISTOPLASMOSIS DISSEMINATED 127 0.0800
86 LIVE BIRTH 660 0.0788
87 WOUND INFECTION 854 0.0779
88 LYMPHOPROLIFERATIVE DISORDER 229 0.0779
89 ANAL FISSURE 417 0.0777
90 ANAL ABSCESS 413 0.0766
91 JOINT RANGE OF MOTION DECREASED 1017 0.0758
92 PERICARDITIS 1265 0.0752
93 BLEPHAROSPASM 472 0.0749
94 SMALL INTESTINAL RESECTION 87 0.0746
95 FISTULA 839 0.0746
96 EXOSTOSIS 675 0.0738
97 HEART TRANSPLANT REJECTION 76 0.0732
98 BLOOD PRESSURE DIASTOLIC ABNORMAL 186 0.0731
99 LIP DRY 662 0.0728
100 GASTROINTESTINAL WALL THICKENING 105 0.0701
101 DISSEMINATED TUBERCULOSIS 177 0.0689
102 CROHN'S DISEASE 470 0.0685
103 ERYTHEMA NODOSUM 240 0.0683
104 BURSITIS 829 0.0683
105 JOINT DISLOCATION 722 0.0682
106 LISTERIOSIS 74 0.0669
107 FINGER DEFORMITY 319 0.0658
108 EPSTEIN-BARR VIRUS INFECTION 407 0.0651
109 ILEOSTOMY 166 0.0650
110 THERAPEUTIC REACTION TIME DECREASED 185 0.0634
111 DEMYELINATION 257 0.0627
112 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 75 0.0625
113 FOOT DEFORMITY 683 0.0616
114 NEUROMYELITIS OPTICA SPECTRUM DISORDER 83 0.0615
115 MATERNAL EXPOSURE TIMING UNSPECIFIED 231 0.0614
116 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 143 0.0614
117 RECTAL ABSCESS 103 0.0613
118 PLEURITIC PAIN 169 0.0612
119 NOCARDIOSIS 156 0.0609
120 ENTHESOPATHY 95 0.0607
121 MYASTHENIA GRAVIS CRISIS 90 0.0607
122 FEMALE GENITAL TRACT FISTULA 103 0.0603
123 COLITIS ULCERATIVE 2666 0.0596
124 DRUG SPECIFIC ANTIBODY PRESENT 385 0.0591
125 ASPERGILLOSIS 76 0.0581
126 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 378 0.0581
127 DRUG LEVEL ABOVE THERAPEUTIC 264 0.0576
128 AUTOIMMUNE DISORDER 558 0.0572
129 CHOLANGITIS SCLEROSING 117 0.0569
130 PULMONARY FIBROSIS 1087 0.0566
131 VASCULITIS 660 0.0566
132 LYMPHADENITIS 137 0.0565
133 DRUG LEVEL DECREASED 574 0.0563
134 STEROID DIABETES 84 0.0560
135 NORMOCHROMIC NORMOCYTIC ANAEMIA 168 0.0559
136 TENOSYNOVITIS 153 0.0554
137 FORCED EXPIRATORY VOLUME DECREASED 157 0.0554
138 CYTOMEGALOVIRUS VIRAEMIA 246 0.0552
139 MYCOBACTERIAL INFECTION 95 0.0551
140 SPONDYLITIS 200 0.0549
141 SYSTEMIC LUPUS ERYTHEMATOSUS 1935 0.0545
142 CENTRAL NERVOUS SYSTEM LYMPHOMA 75 0.0544
143 KIDNEY TRANSPLANT REJECTION 259 0.0539
144 CONTRAINDICATED PRODUCT ADMINISTERED 1623 0.0536
145 DRUG SPECIFIC ANTIBODY 73 0.0533
146 NORMAL NEWBORN 288 0.0529
147 VARICELLA ZOSTER VIRUS INFECTION 109 0.0525
148 HISTIOCYTOSIS HAEMATOPHAGIC 156 0.0525
149 INFUSION SITE REACTION 156 0.0522
150 GLOSSODYNIA 1169 0.0522
151 GASTROINTESTINAL STOMA COMPLICATION 82 0.0521
152 HISTOPLASMOSIS 92 0.0519
153 DEATH NEONATAL 72 0.0517
154 TRANSPLANT REJECTION 413 0.0515
155 PNEUMONIA CYTOMEGALOVIRAL 100 0.0514
156 STENOSIS 96 0.0511
157 C-REACTIVE PROTEIN INCREASED 1857 0.0510
158 INTESTINAL RESECTION 272 0.0505
159 GASTROINTESTINAL INFLAMMATION 394 0.0502
160 CYTOMEGALOVIRUS INFECTION 835 0.0502
161 NAIL DISORDER 439 0.0501
162 ABDOMINAL ADHESIONS 157 0.0497
163 NEOPLASM SKIN 76 0.0489
164 ANTINUCLEAR ANTIBODY POSITIVE 158 0.0486
165 ABSCESS INTESTINAL 104 0.0483
166 PROCTITIS 135 0.0481
167 FIBROMYALGIA 1165 0.0479
168 LIVER FUNCTION TEST INCREASED 1024 0.0476
169 PYODERMA GANGRENOSUM 170 0.0472
170 PULMONARY ALVEOLAR HAEMORRHAGE 262 0.0467
171 INTESTINAL ULCER 74 0.0465
172 PULMONARY TUBERCULOSIS 198 0.0463
173 THERAPEUTIC PRODUCT EFFECT DECREASED 2068 0.0461
174 CYTOMEGALOVIRUS CHORIORETINITIS 90 0.0461
175 IRRITABLE BOWEL SYNDROME 987 0.0460
176 BACK INJURY 500 0.0459
177 WOUND 1280 0.0457
178 CONGENITAL ANOMALY 353 0.0456
179 WALKING AID USER 300 0.0455
180 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 150 0.0454
181 SQUAMOUS CELL CARCINOMA OF SKIN 273 0.0452
182 NEUROLOGICAL SYMPTOM 258 0.0451
183 BODY TEMPERATURE FLUCTUATION 94 0.0451
184 PRE-ECLAMPSIA 214 0.0450
185 COMPLICATIONS OF TRANSPLANTED KIDNEY 102 0.0449
186 BLOOD PRESSURE SYSTOLIC ABNORMAL 111 0.0449
187 LIVER TRANSPLANT REJECTION 80 0.0445
188 PNEUMOCYSTIS JIROVECII PNEUMONIA 446 0.0444
189 PRODUCT LABEL CONFUSION 257 0.0441
190 DIFFUSE LARGE B-CELL LYMPHOMA 338 0.0438
191 DERMATOMYOSITIS 111 0.0438
192 SKIN NECROSIS 225 0.0433
193 LARGE INTESTINAL ULCER 117 0.0431
194 HEPATIC CIRRHOSIS 805 0.0428
195 BASAL CELL CARCINOMA 658 0.0421
196 ANORECTAL DISORDER 84 0.0421
197 FREQUENT BOWEL MOVEMENTS 1126 0.0416
198 LOW BIRTH WEIGHT BABY 331 0.0416
199 APHTHOUS ULCER 322 0.0415
200 B-CELL LYMPHOMA 141 0.0415
201 DIARRHOEA HAEMORRHAGIC 388 0.0415
202 OBESITY 657 0.0412
203 ACTINIC KERATOSIS 106 0.0408
204 MUCOUS STOOLS 202 0.0407
205 ABSCESS 645 0.0404
206 AUTOIMMUNE HEPATITIS 279 0.0401
207 FOETAL GROWTH RESTRICTION 242 0.0398
208 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 326 0.0395
209 LOSS OF THERAPEUTIC RESPONSE 126 0.0395
210 TREATMENT FAILURE 3257 0.0393
211 DEFAECATION URGENCY 275 0.0392
212 SACROILIITIS 74 0.0392
213 LIVER INJURY 962 0.0392
214 INFUSION RELATED REACTION 2592 0.0391
215 CREPITATIONS 116 0.0389
216 DRUG INTOLERANCE 3762 0.0389
217 PORTAL HYPERTENSION 119 0.0385
218 PREMATURE LABOUR 218 0.0385
219 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 95 0.0384
220 IMPAIRED HEALING 1255 0.0382
221 INTENTIONAL PRODUCT USE ISSUE 3345 0.0381
222 ABDOMINAL ABSCESS 168 0.0380
223 MYASTHENIA GRAVIS 307 0.0380
224 SQUAMOUS CELL CARCINOMA 357 0.0379
225 SERUM SICKNESS 105 0.0376
226 SCIATICA 597 0.0374
227 FOOD INTOLERANCE 137 0.0374
228 BLOOD PRESSURE DIASTOLIC INCREASED 171 0.0370
229 SUBCUTANEOUS ABSCESS 177 0.0369
230 CYTOMEGALOVIRUS INFECTION REACTIVATION 163 0.0369
231 COELIAC DISEASE 358 0.0365
232 COLECTOMY 206 0.0364
233 APLASIA PURE RED CELL 124 0.0360
234 BRAIN ABSCESS 91 0.0359
235 HEPATOSPLENOMEGALY 92 0.0358
236 INFLAMMATION 1846 0.0357
237 VARICELLA 85 0.0355
238 JOINT STIFFNESS 933 0.0355
239 PREMATURE DELIVERY 565 0.0354
240 GRANULOMA 122 0.0352
241 BLOOD PRESSURE DIASTOLIC DECREASED 259 0.0351
242 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 82 0.0350
243 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 260 0.0346
244 BLOOD PRESSURE FLUCTUATION 826 0.0344
245 ARTHROPATHY 1912 0.0344
246 LUNG ABSCESS 72 0.0343
247 TYPE 2 DIABETES MELLITUS 1137 0.0337
248 HYPOGAMMAGLOBULINAEMIA 219 0.0333
249 PNEUMOCYSTIS JIROVECI PNEUMONIA 74 0.0332
250 PSORIATIC ARTHROPATHY 1348 0.0332
251 OSTEOARTHRITIS 1407 0.0332
252 TRANSPLANT FAILURE 81 0.0330
253 SPINAL FUSION SURGERY 133 0.0328
254 MYCOBACTERIUM AVIUM COMPLEX INFECTION 86 0.0320
255 DRUG-INDUCED LIVER INJURY 1005 0.0320
256 RHEUMATOID ARTHRITIS 3629 0.0319
257 ENTERITIS 204 0.0318
258 POOR VENOUS ACCESS 329 0.0318
259 HYPERSENSITIVITY VASCULITIS 83 0.0316
260 HEPATITIS 799 0.0312
261 PREMATURE RUPTURE OF MEMBRANES 75 0.0311
262 PROCTALGIA 197 0.0306
263 LYMPHOPENIA 433 0.0306
264 PNEUMATOSIS INTESTINALIS 87 0.0305
265 POLYARTHRITIS 160 0.0303
266 LOWER RESPIRATORY TRACT INFECTION 1362 0.0299
267 EXPOSURE DURING PREGNANCY 1859 0.0299
268 DRUG TOLERANCE 151 0.0298
269 SMALL INTESTINAL OBSTRUCTION 365 0.0296
270 UVEITIS 400 0.0295
271 FULL BLOOD COUNT ABNORMAL 310 0.0293
272 NIGHT SWEATS 942 0.0292
273 CLOSTRIDIUM DIFFICILE INFECTION 634 0.0290
274 HEPATIC ENZYME INCREASED 1979 0.0290
275 DYSCHEZIA 88 0.0288
276 HEPATIC FIBROSIS 98 0.0285
277 MATERNAL EXPOSURE DURING PREGNANCY 2538 0.0284
278 DRUG ERUPTION 503 0.0284
279 HIP ARTHROPLASTY 434 0.0283
280 AUTOIMMUNE HAEMOLYTIC ANAEMIA 97 0.0283
281 IMMUNOSUPPRESSION 247 0.0280
282 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1984 0.0279
283 PREMATURE BABY 831 0.0276
284 GAIT INABILITY 922 0.0276
285 IRON DEFICIENCY 123 0.0273
286 ULCER 435 0.0273
287 OBSTRUCTION 109 0.0273
288 OSTEOPOROSIS 1119 0.0272
289 LUNG DISORDER 1330 0.0271
290 BLOOD CHOLESTEROL INCREASED 1256 0.0269
291 THROMBOTIC MICROANGIOPATHY 259 0.0266
292 NODULE 343 0.0263
293 BRONCHIECTASIS 177 0.0262
294 EAR INFECTION 698 0.0262
295 SYNOVIAL CYST 121 0.0262
296 SKIN PAPILLOMA 105 0.0262
297 HERPES SIMPLEX 170 0.0261
298 BLOOD PRESSURE SYSTOLIC INCREASED 505 0.0259
299 KLEBSIELLA INFECTION 130 0.0257
300 BODY TEMPERATURE DECREASED 252 0.0256
301 HAEMATOCHEZIA 1403 0.0254
302 PRESCRIBED UNDERDOSE 506 0.0253
303 ARTERIOSCLEROSIS CORONARY ARTERY 168 0.0253
304 LOWER LIMB FRACTURE 486 0.0253
305 CUTANEOUS VASCULITIS 92 0.0252
306 ASPERGILLUS INFECTION 165 0.0251
307 THERAPY NON-RESPONDER 1120 0.0249
308 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 417 0.0245
309 INTESTINAL OBSTRUCTION 923 0.0245
310 BREATH SOUNDS ABNORMAL 119 0.0241
311 OESOPHAGEAL CANDIDIASIS 96 0.0241
312 BRONCHOPULMONARY ASPERGILLOSIS 186 0.0240
313 TONSILLITIS 125 0.0239
314 PSEUDOMONAS INFECTION 205 0.0239
315 OBSTRUCTIVE AIRWAYS DISORDER 265 0.0238
316 LARGE INTESTINE POLYP 165 0.0238
317 INTESTINAL PERFORATION 265 0.0236
318 IRON DEFICIENCY ANAEMIA 217 0.0235
319 MATERNAL EXPOSURE DURING BREAST FEEDING 95 0.0234
320 LEUKOPENIA 1169 0.0233
321 MYOSITIS 209 0.0233
322 MYOPATHY 201 0.0232
323 JOINT EFFUSION 160 0.0232
324 INFLAMMATORY MARKER INCREASED 115 0.0232
325 RENAL CELL CARCINOMA 113 0.0231
326 COLITIS 873 0.0230
327 JOINT SWELLING 2759 0.0228
328 WHEEZING 1348 0.0227
329 MUSCULOSKELETAL STIFFNESS 1988 0.0227
330 ADVERSE REACTION 300 0.0226
331 LUNG INFILTRATION 198 0.0224
332 SUSPECTED OFF LABEL USE 101 0.0223
333 ARTHRITIS 1755 0.0223
334 NEONATAL RESPIRATORY DISTRESS SYNDROME 78 0.0220
335 PRESCRIBED OVERDOSE 426 0.0220
336 CONDITION AGGRAVATED 6678 0.0219
337 PROTEINURIA 416 0.0219
338 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1050 0.0218
339 PULMONARY MASS 324 0.0217
340 SCLERODERMA 79 0.0217
341 CHRONIC GRAFT VERSUS HOST DISEASE 78 0.0216
342 APPENDICECTOMY 77 0.0216
343 SKIN INFECTION 240 0.0214
344 PANCREATITIS 1130 0.0214
345 GASTROINTESTINAL INFECTION 191 0.0213
346 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 81 0.0212
347 SKIN ULCER 546 0.0211
348 STAPHYLOCOCCAL SEPSIS 104 0.0210
349 HYPERCALCAEMIA 257 0.0208
350 STOMATITIS 1246 0.0205
351 HEPATOTOXICITY 457 0.0205
352 PANCYTOPENIA 1145 0.0205
353 DISEASE RECURRENCE 959 0.0201
354 RECTAL HAEMORRHAGE 862 0.0200
355 MOBILITY DECREASED 1440 0.0200
356 BLISTER 1124 0.0200
357 MUSCULOSKELETAL PAIN 1044 0.0199
358 INFUSION SITE EXTRAVASATION 124 0.0199
359 INFLAMMATORY BOWEL DISEASE 194 0.0198
360 THERAPY PARTIAL RESPONDER 309 0.0198
361 SARCOIDOSIS 94 0.0198
362 WEIGHT FLUCTUATION 207 0.0198
363 HAEMOLYSIS 152 0.0197
364 PYELONEPHRITIS 170 0.0196
365 HEART RATE DECREASED 687 0.0195
366 TASTE DISORDER 396 0.0195
367 ABSCESS LIMB 83 0.0195
368 EPILEPSY 595 0.0194
369 KNEE ARTHROPLASTY 409 0.0194
370 UPPER RESPIRATORY TRACT INFECTION 895 0.0194
371 GASTROINTESTINAL DISORDER 1723 0.0192
372 REBOUND EFFECT 216 0.0191
373 ENTEROCOCCAL INFECTION 92 0.0190
374 FLANK PAIN 178 0.0190
375 ANKYLOSING SPONDYLITIS 247 0.0187
376 PREGNANCY 373 0.0186
377 ARTHRITIS BACTERIAL 76 0.0185
378 GESTATIONAL DIABETES 88 0.0184
379 EOSINOPHIL COUNT INCREASED 153 0.0183
380 FUNGAL SKIN INFECTION 74 0.0183
381 TENDERNESS 191 0.0183
382 ARTERIOSCLEROSIS 171 0.0182
383 ESCHERICHIA URINARY TRACT INFECTION 77 0.0181
384 MOUTH ULCERATION 378 0.0179
385 FOETAL DEATH 93 0.0179
386 HEPATITIS CHOLESTATIC 108 0.0179
387 BONE MARROW FAILURE 363 0.0178
388 ABDOMINAL HERNIA 81 0.0177
389 PURULENT DISCHARGE 75 0.0175
390 NEPHROPATHY TOXIC 197 0.0175
391 SPLENOMEGALY 205 0.0175
392 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 960 0.0175
393 FAECES SOFT 127 0.0174
394 THERAPEUTIC RESPONSE SHORTENED 579 0.0174
395 IMPAIRED GASTRIC EMPTYING 237 0.0174
396 CANDIDA INFECTION 293 0.0173
397 LIVER DISORDER 768 0.0173
398 INJECTION SITE INFLAMMATION 86 0.0172
399 IMMUNE THROMBOCYTOPENIA 79 0.0172
400 BREAST CANCER STAGE II 143 0.0172
401 ESCHERICHIA INFECTION 141 0.0171
402 ABDOMINAL TENDERNESS 85 0.0171
403 GRAFT VERSUS HOST DISEASE 123 0.0171
404 FOETAL EXPOSURE DURING PREGNANCY 1384 0.0170
405 BACTERAEMIA 202 0.0170
406 ULCER HAEMORRHAGE 115 0.0170
407 THERAPEUTIC RESPONSE DECREASED 1028 0.0169
408 NEUTROPHIL COUNT INCREASED 173 0.0169
409 NECROSIS 94 0.0169
410 ABDOMINAL PAIN 3884 0.0167
411 MALNUTRITION 185 0.0165
412 BLOOD ALBUMIN DECREASED 131 0.0165
413 HERPES VIRUS INFECTION 95 0.0165
414 INFECTION 2361 0.0163
415 HEPATITIS B 98 0.0162
416 RHINITIS 131 0.0162
417 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 155 0.0162
418 BOWEL MOVEMENT IRREGULARITY 124 0.0162
419 MENINGITIS 108 0.0162
420 HERPES ZOSTER 928 0.0161
421 CAESAREAN SECTION 186 0.0160
422 DYSLIPIDAEMIA 81 0.0159
423 UROSEPSIS 147 0.0159
424 ODYNOPHAGIA 95 0.0159
425 IMMUNODEFICIENCY 237 0.0159
426 CYTOPENIA 194 0.0158
427 LARGE INTESTINE PERFORATION 110 0.0158
428 ILL-DEFINED DISORDER 962 0.0158
429 PNEUMONIA BACTERIAL 145 0.0158
430 GASTROENTERITIS 230 0.0157
431 NEPHROTIC SYNDROME 108 0.0157
432 CLOSTRIDIUM DIFFICILE COLITIS 167 0.0157
433 ATELECTASIS 152 0.0157
434 SWELLING 1465 0.0156
435 GENERAL PHYSICAL HEALTH DETERIORATION 1809 0.0156
436 DISCOMFORT 953 0.0156
437 INTERSTITIAL LUNG DISEASE 756 0.0156
438 OFF LABEL USE 13607 0.0155
439 PHARYNGITIS 190 0.0153
440 PANCREATITIS ACUTE 343 0.0152
441 RALES 88 0.0151
442 SEPTIC SHOCK 658 0.0151
443 RASH VESICULAR 73 0.0151
444 MULTIPLE ORGAN DYSFUNCTION SYNDROME 427 0.0151
445 HEPATIC ENZYME ABNORMAL 75 0.0150
446 BLOOD IRON DECREASED 177 0.0149
447 INJURY 1048 0.0149
448 ORAL CANDIDIASIS 195 0.0148
449 LYMPHOMA 228 0.0147
450 FEAR OF INJECTION 105 0.0147
451 PRODUCTIVE COUGH 701 0.0147
452 HAEMOPTYSIS 408 0.0146
453 ENDOCARDITIS 75 0.0146
454 SPUTUM DISCOLOURED 138 0.0145
455 DELIRIUM 501 0.0144
456 HEART RATE IRREGULAR 326 0.0144
457 DISSEMINATED INTRAVASCULAR COAGULATION 203 0.0144
458 HYPOALBUMINAEMIA 112 0.0144
459 APPENDICITIS 134 0.0143
460 SLEEP DISORDER 1011 0.0143
461 ABNORMAL FAECES 117 0.0143
462 ARTHRALGIA 5936 0.0143
463 ANAL INCONTINENCE 128 0.0142
464 RESPIRATORY DISORDER 424 0.0142
465 SINUSITIS 1449 0.0141
466 OEDEMA 764 0.0141
467 COVID-19 PNEUMONIA 165 0.0140
468 OPTIC NEURITIS 126 0.0139
469 NECK PAIN 775 0.0139
470 STREPTOCOCCAL INFECTION 77 0.0138
471 LYMPHADENOPATHY 489 0.0138
472 MUSCULAR WEAKNESS 1569 0.0138
473 SEPSIS 1537 0.0138
474 ROAD TRAFFIC ACCIDENT 576 0.0138
475 ENCEPHALITIS 94 0.0136
476 HYPERTRANSAMINASAEMIA 94 0.0135
477 PLEURISY 80 0.0135
478 HYPERSENSITIVITY 2495 0.0134
479 WEIGHT INCREASED 2970 0.0132
480 SKIN CANCER 285 0.0132
481 HEPATIC FUNCTION ABNORMAL 494 0.0132
482 CYST 164 0.0132
483 SKIN LESION 362 0.0132
484 OSTEOMYELITIS 238 0.0131
485 TRANSAMINASES INCREASED 292 0.0131
486 HYPERTENSION 2771 0.0131
487 ENTEROCOLITIS 75 0.0130
488 NASOPHARYNGITIS 2386 0.0129
489 LIPASE INCREASED 99 0.0129
490 MATERNAL EXPOSURE BEFORE PREGNANCY 88 0.0129
491 POSTOPERATIVE WOUND INFECTION 87 0.0129
492 MALIGNANT MELANOMA 172 0.0128
493 POLYP 84 0.0128
494 TYPE 1 DIABETES MELLITUS 77 0.0128
495 RASH PUSTULAR 93 0.0128
496 PRODUCT USE ISSUE 2393 0.0127
497 TONGUE DISORDER 91 0.0126
498 RENAL TUBULAR NECROSIS 123 0.0125
499 DISABILITY 247 0.0125
500 PERIPHERAL SWELLING 1922 0.0125
501 PNEUMONIA 4030 0.0124
502 STAPHYLOCOCCAL INFECTION 410 0.0124
503 MYELODYSPLASTIC SYNDROME 179 0.0124
504 BACTERIAL INFECTION 230 0.0123
505 HYPOAESTHESIA 1840 0.0123
506 PHARYNGITIS STREPTOCOCCAL 133 0.0123
507 ABDOMINAL DISCOMFORT 2056 0.0122
508 WEIGHT DECREASED 3421 0.0122
509 DRUG RESISTANCE 314 0.0122
510 HEPATOMEGALY 120 0.0122
511 CONCUSSION 94 0.0121
512 CONJUNCTIVITIS 225 0.0121
513 TOOTH INFECTION 159 0.0120
514 GASTROOESOPHAGEAL REFLUX DISEASE 969 0.0120
515 DRUG LEVEL INCREASED 199 0.0120
516 PURPURA 106 0.0120
517 VIRAL INFECTION 398 0.0119
518 DRY MOUTH 967 0.0119
519 PYREXIA 4118 0.0119
520 EAR PAIN 231 0.0119
521 ACUTE RESPIRATORY DISTRESS SYNDROME 210 0.0119
522 ABDOMINAL PAIN LOWER 299 0.0118
523 NEPHROLITHIASIS 541 0.0118
524 INFUSION SITE PAIN 151 0.0117
525 POST PROCEDURAL COMPLICATION 225 0.0117
526 RESPIRATORY TRACT INFECTION 305 0.0117
527 ANAPHYLACTIC REACTION 643 0.0116
528 GASTROINTESTINAL PAIN 128 0.0116
529 RENAL IMPAIRMENT 976 0.0116
530 INFUSION SITE SWELLING 73 0.0116
531 POST PROCEDURAL INFECTION 94 0.0115
532 TOOTH ABSCESS 117 0.0115
533 ABDOMINAL DISTENSION 1198 0.0115
534 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2068 0.0115
535 LOCALISED INFECTION 277 0.0114
536 OVARIAN CYST 114 0.0114
537 BODY TEMPERATURE INCREASED 232 0.0114
538 PLATELET COUNT INCREASED 148 0.0113
539 ATRIAL SEPTAL DEFECT 95 0.0113
540 DYSPEPSIA 1111 0.0113
541 MULTI-ORGAN FAILURE 194 0.0112
542 IMPAIRED WORK ABILITY 239 0.0112
543 PRODUCT USE IN UNAPPROVED INDICATION 2770 0.0112
544 MIGRAINE 1066 0.0112
545 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 191 0.0111
546 ALOPECIA 2183 0.0111
547 SINUS CONGESTION 150 0.0111
548 HAEMODIALYSIS 93 0.0111
549 BRONCHITIS 816 0.0110
550 ABORTION SPONTANEOUS 438 0.0109
551 OSTEONECROSIS 357 0.0109
552 HYPOTHYROIDISM 346 0.0108
553 UTERINE LEIOMYOMA 79 0.0108
554 WHITE BLOOD CELL COUNT INCREASED 413 0.0108
555 FURUNCLE 85 0.0107
556 ACUTE MYELOID LEUKAEMIA 167 0.0107
557 ASTHMA 1206 0.0107
558 VITAMIN D DECREASED 91 0.0106
559 RESPIRATORY FAILURE 775 0.0106
560 EYE INFLAMMATION 101 0.0106
561 ASCITES 311 0.0106
562 HYDRONEPHROSIS 79 0.0105
563 PETECHIAE 110 0.0105
564 URTICARIA 1756 0.0105
565 QUALITY OF LIFE DECREASED 140 0.0104
566 NEUTROPENIC SEPSIS 74 0.0104
567 HAEMORRHOIDS 201 0.0103
568 BLOOD CREATININE INCREASED 671 0.0103
569 RENAL FAILURE CHRONIC 79 0.0103
570 LIVER FUNCTION TEST ABNORMAL 298 0.0102
571 OROPHARYNGEAL PAIN 946 0.0102
572 INFLUENZA 1134 0.0102
573 PAIN IN EXTREMITY 2993 0.0101
574 CHOLESTASIS 195 0.0101
575 HIDRADENITIS 92 0.0101
576 DRUG INEFFECTIVE 13174 0.0100
577 ARTHROPOD BITE 74 0.0100
578 FUNGAL INFECTION 332 0.0100
579 MUSCULOSKELETAL DISCOMFORT 171 0.0099
580 DERMATITIS 208 0.0099
581 DIABETES MELLITUS 756 0.0099
582 RESPIRATORY RATE INCREASED 88 0.0099
583 GROIN PAIN 87 0.0099
584 ILEUS 123 0.0099
585 SKIN LACERATION 107 0.0098
586 OEDEMA PERIPHERAL 1198 0.0098
587 HYPOXIA 345 0.0098
588 CARPAL TUNNEL SYNDROME 137 0.0098
589 MYOCARDITIS 112 0.0098
590 PHOTOSENSITIVITY REACTION 161 0.0097
591 DEFORMITY 91 0.0097
592 INJECTION SITE REACTION 667 0.0097
593 ALANINE AMINOTRANSFERASE INCREASED 593 0.0096
594 PELVIC FRACTURE 75 0.0096
595 HEPATIC STEATOSIS 179 0.0096
596 TUBULOINTERSTITIAL NEPHRITIS 180 0.0096
597 MUSCLE SPASTICITY 118 0.0096
598 SPINAL OSTEOARTHRITIS 84 0.0096
599 ADRENAL INSUFFICIENCY 116 0.0095
600 CONTUSION 915 0.0095
601 OSTEOPENIA 143 0.0094
602 MASS 131 0.0094
603 LABORATORY TEST ABNORMAL 276 0.0093
604 OESOPHAGITIS 102 0.0093
605 CELLULITIS 469 0.0093
606 OXYGEN SATURATION DECREASED 521 0.0093
607 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 237 0.0092
608 ASPARTATE AMINOTRANSFERASE INCREASED 489 0.0092
609 SKIN DISORDER 307 0.0092
610 SPINAL COMPRESSION FRACTURE 76 0.0092
611 MUSCLE SPASMS 1683 0.0092
612 BLOOD PRESSURE INCREASED 1393 0.0091
613 HAEMOGLOBIN DECREASED 935 0.0091
614 HAEMOLYTIC ANAEMIA 81 0.0090
615 HERNIA 174 0.0090
616 MUSCULOSKELETAL DISORDER 171 0.0090
617 PNEUMOTHORAX 142 0.0089
618 SECRETION DISCHARGE 112 0.0089
619 URINARY TRACT INFECTION 1523 0.0089
620 KIDNEY INFECTION 175 0.0089
621 DEVICE RELATED INFECTION 137 0.0089
622 COAGULOPATHY 148 0.0089
623 EYE INFECTION 100 0.0088
624 MITRAL VALVE INCOMPETENCE 100 0.0088
625 AMNESIA 574 0.0088
626 VITAMIN D DEFICIENCY 86 0.0088
627 GOUT 158 0.0088
628 VISUAL IMPAIRMENT 1090 0.0088
629 ABDOMINAL PAIN UPPER 1806 0.0088
630 TENDONITIS 135 0.0087
631 PERITONITIS 180 0.0087
632 ANAEMIA 1655 0.0087
633 PHOTOPHOBIA 163 0.0087
634 NASAL CONGESTION 509 0.0087
635 DIARRHOEA 5589 0.0086
636 LYMPHOCYTE COUNT DECREASED 153 0.0086
637 GASTRIC ULCER 164 0.0086
638 MALAISE 3779 0.0086
639 RED BLOOD CELL COUNT DECREASED 245 0.0086
640 LEUKOCYTOSIS 155 0.0086
641 EYELID PTOSIS 87 0.0086
642 IMPAIRED QUALITY OF LIFE 123 0.0085
643 ORAL HERPES 167 0.0085
644 MYELOSUPPRESSION 308 0.0085
645 CHOLELITHIASIS 279 0.0085
646 PAIN IN JAW 241 0.0085
647 JAUNDICE 228 0.0085
648 DIVERTICULITIS 234 0.0084
649 RASH PRURITIC 453 0.0083
650 COVID-19 1464 0.0083
651 TACHYCARDIA 732 0.0082
652 CATARACT 490 0.0082
653 MEMORY IMPAIRMENT 1128 0.0082
654 GASTRITIS 216 0.0082
655 COLON CANCER 122 0.0082
656 CONFUSIONAL STATE 1319 0.0082
657 CHEST PAIN 1509 0.0081
658 ADVERSE DRUG REACTION 730 0.0081
659 ACUTE HEPATIC FAILURE 111 0.0081
660 HAEMATURIA 278 0.0081
661 RASH 3533 0.0081
662 JOINT INJURY 172 0.0080
663 MUSCLE ATROPHY 102 0.0080
664 GLAUCOMA 155 0.0080
665 THROMBOSIS 646 0.0080
666 RESPIRATORY TRACT CONGESTION 127 0.0080
667 GASTROENTERITIS VIRAL 144 0.0080
668 PARAESTHESIA 1247 0.0079
669 GENERALISED OEDEMA 98 0.0079
670 VOMITING 3720 0.0079
671 DRUG EFFECT INCOMPLETE 285 0.0078
672 HAEMATOCRIT DECREASED 155 0.0078
673 IMMUNE SYSTEM DISORDER 103 0.0078
674 CHOLECYSTECTOMY 89 0.0078
675 NEOPLASM 89 0.0077
676 RIB FRACTURE 159 0.0077
677 BLOOD LACTATE DEHYDROGENASE INCREASED 122 0.0077
678 ADVERSE EVENT 708 0.0077
679 DRUG EXPOSURE DURING PREGNANCY 260 0.0076
680 HEPATIC FAILURE 230 0.0076
681 SCAR 129 0.0075
682 DECREASED APPETITE 1746 0.0075
683 HYPERLIPIDAEMIA 89 0.0074
684 TOOTH FRACTURE 82 0.0074
685 DRUG INTERACTION 1180 0.0074
686 ACUTE RESPIRATORY FAILURE 143 0.0074
687 THROMBOCYTOPENIA 831 0.0074
688 ATAXIA 88 0.0074
689 LUNG INFECTION 115 0.0074
690 PULMONARY HYPERTENSION 154 0.0074
691 RHINORRHOEA 475 0.0073
692 COUGH 2054 0.0073
693 PLEURAL EFFUSION 441 0.0072
694 ASTHENIA 2713 0.0072
695 HEADACHE 4507 0.0072
696 CHILLS 841 0.0072
697 SPINAL PAIN 84 0.0072
698 EPISTAXIS 536 0.0072
699 LIMB DISCOMFORT 221 0.0071
700 HEART RATE INCREASED 707 0.0071
701 RESPIRATORY DISTRESS 196 0.0071
702 SKIN REACTION 100 0.0071
703 DYSPNOEA EXERTIONAL 267 0.0071
704 FEELING HOT 434 0.0071
705 PAIN 4297 0.0070
706 BLOOD ALKALINE PHOSPHATASE INCREASED 173 0.0070
707 INTERVERTEBRAL DISC PROTRUSION 152 0.0069
708 CYSTITIS 221 0.0069
709 SCAB 79 0.0069
710 HYPOPHAGIA 176 0.0069
711 END STAGE RENAL DISEASE 125 0.0068
712 DEPRESSION 1549 0.0068
713 SEASONAL ALLERGY 96 0.0068
714 DYSPNOEA 3837 0.0068
715 PERICARDIAL EFFUSION 156 0.0067
716 FATIGUE 5246 0.0067
717 PULMONARY EMBOLISM 640 0.0067
718 NAUSEA 5308 0.0067
719 EOSINOPHILIA 117 0.0067
720 TOOTH EXTRACTION 82 0.0066
721 INTENTIONAL DOSE OMISSION 187 0.0066
722 FEEDING DISORDER 133 0.0066
723 HEPATITIS C 79 0.0065
724 INFLUENZA LIKE ILLNESS 538 0.0065
725 NO THERAPEUTIC RESPONSE 79 0.0065
726 BLOOD TEST ABNORMAL 91 0.0065
727 NEUTROPENIA 880 0.0065
728 FLATULENCE 367 0.0065
729 PERIPHERAL COLDNESS 88 0.0064
730 DIPLOPIA 166 0.0064
731 GAIT DISTURBANCE 1218 0.0064
732 SINUS DISORDER 126 0.0064
733 SARS-COV-2 TEST POSITIVE 84 0.0064
734 DRUG EFFECT DECREASED 342 0.0063
735 WRIST FRACTURE 76 0.0063
736 UNDERDOSE 462 0.0063
737 BLOOD PRESSURE DECREASED 420 0.0063
738 BONE DISORDER 115 0.0063
739 FEELING JITTERY 119 0.0062
740 BLOOD CREATINE PHOSPHOKINASE INCREASED 179 0.0062
741 PALLOR 169 0.0062
742 INJECTION SITE HAEMATOMA 90 0.0062
743 MUSCULOSKELETAL CHEST PAIN 95 0.0061
744 POOR QUALITY SLEEP 132 0.0061
745 THROAT IRRITATION 275 0.0061
746 BLOOD POTASSIUM DECREASED 183 0.0061
747 RASH PAPULAR 136 0.0061
748 BLOOD UREA INCREASED 101 0.0060
749 HIATUS HERNIA 78 0.0060
750 PNEUMONITIS 164 0.0060
751 APHONIA 84 0.0060
752 INJECTION SITE EXTRAVASATION 74 0.0060
753 ERYTHEMA 1229 0.0060
754 ACUTE KIDNEY INJURY 914 0.0060
755 DEEP VEIN THROMBOSIS 388 0.0060
756 PSORIASIS 779 0.0060
757 TACHYPNOEA 81 0.0060
758 DISEASE PROGRESSION 703 0.0059
759 TOOTHACHE 107 0.0059
760 INSOMNIA 1569 0.0059
761 SURGERY 344 0.0059
762 MELAENA 129 0.0059
763 CARDIOMEGALY 72 0.0058
764 HEMIPARESIS 99 0.0058
765 ENCEPHALOPATHY 143 0.0058
766 NEOPLASM MALIGNANT 388 0.0058
767 FOOT FRACTURE 110 0.0058
768 CARDIOVASCULAR DISORDER 147 0.0058
769 PRODUCT PRESCRIBING ISSUE 126 0.0058
770 RENAL FAILURE 768 0.0058
771 HYPERKALAEMIA 202 0.0058
772 TOOTH DISORDER 128 0.0058
773 PRURITUS 2210 0.0057
774 METASTASES TO LIVER 101 0.0057
775 MYALGIA 972 0.0057
776 PARAESTHESIA ORAL 82 0.0057
777 EATING DISORDER 121 0.0057
778 CENTRAL NERVOUS SYSTEM LESION 78 0.0057
779 BACK PAIN 1317 0.0057
780 RASH MACULO-PAPULAR 126 0.0057
781 GASTRIC DISORDER 194 0.0056
782 SHOCK 130 0.0056
783 RENAL FAILURE ACUTE 236 0.0056
784 TREATMENT NONCOMPLIANCE 304 0.0056
785 DIZZINESS 2750 0.0055
786 SWELLING FACE 358 0.0055
787 DEHYDRATION 731 0.0055
788 UPPER LIMB FRACTURE 109 0.0055
789 HAEMORRHAGE 569 0.0054
790 AGRANULOCYTOSIS 101 0.0054
791 ANGIOEDEMA 240 0.0054
792 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 158 0.0054
793 WHITE BLOOD CELL COUNT DECREASED 583 0.0054
794 ANXIETY 1530 0.0054
795 DYSURIA 193 0.0052
796 PROCEDURAL PAIN 145 0.0052
797 BLOOD URINE PRESENT 99 0.0052
798 GALLBLADDER DISORDER 93 0.0052
799 CARDIOMYOPATHY 77 0.0052
800 EYE PAIN 293 0.0052
801 SPINAL FRACTURE 104 0.0052
802 NEURALGIA 126 0.0052
803 PRODUCT PRESCRIBING ERROR 123 0.0052
804 COLD SWEAT 91 0.0052
805 HYPOKALAEMIA 238 0.0052
806 PLATELET COUNT DECREASED 549 0.0051
807 RASH ERYTHEMATOUS 246 0.0051
808 CHROMATURIA 116 0.0051
809 SKIN DISCOLOURATION 236 0.0051
810 HAEMATEMESIS 130 0.0051
811 DEAFNESS 134 0.0051
812 FAECES DISCOLOURED 111 0.0051
813 GAMMA-GLUTAMYLTRANSFERASE INCREASED 113 0.0051
814 CHEST DISCOMFORT 517 0.0050
815 FACE OEDEMA 85 0.0050
816 PULMONARY ARTERIAL HYPERTENSION 73 0.0050
817 OCULAR HYPERAEMIA 239 0.0050
818 MEDICATION ERROR 279 0.0050
819 APHASIA 151 0.0050
820 SLEEP APNOEA SYNDROME 95 0.0050
821 ILLNESS 508 0.0049
822 HYPOTENSION 989 0.0049
823 BLOOD BILIRUBIN INCREASED 133 0.0049
824 ANKLE FRACTURE 76 0.0049
825 THROAT TIGHTNESS 132 0.0049
826 HYPOAESTHESIA ORAL 72 0.0048
827 EYE DISORDER 157 0.0048
828 PRESYNCOPE 116 0.0048
829 DRY EYE 238 0.0048
830 LIMB INJURY 129 0.0047
831 CEREBRAL INFARCTION 116 0.0047
832 DYSPHAGIA 450 0.0047
833 THYROID DISORDER 73 0.0047
834 INJECTION SITE PAIN 1445 0.0047
835 MENTAL DISORDER 205 0.0047
836 ECZEMA 246 0.0047
837 PRODUCT AVAILABILITY ISSUE 106 0.0047
838 BLOOD TRIGLYCERIDES INCREASED 82 0.0046
839 RENAL DISORDER 215 0.0046
840 INJECTION SITE PRURITUS 309 0.0046
841 MOVEMENT DISORDER 148 0.0046
842 LETHARGY 264 0.0046
843 LOCAL SWELLING 80 0.0046
844 NERVOUS SYSTEM DISORDER 143 0.0046
845 CIRCULATORY COLLAPSE 78 0.0046
846 FLUID RETENTION 230 0.0045
847 DYSSTASIA 132 0.0045
848 RHABDOMYOLYSIS 187 0.0045
849 INCORRECT DOSE ADMINISTERED 1020 0.0045
850 INJECTION SITE BRUISING 354 0.0044
851 FALL 1445 0.0043
852 CONSTIPATION 943 0.0043
853 WRONG TECHNIQUE IN DRUG USAGE PROCESS 157 0.0043
854 PALPITATIONS 505 0.0043
855 HYPERGLYCAEMIA 156 0.0043
856 THIRST 76 0.0042
857 PULMONARY OEDEMA 190 0.0042
858 RASH MACULAR 148 0.0042
859 HYPOCALCAEMIA 80 0.0042
860 FEELING COLD 116 0.0042
861 MUCOSAL INFLAMMATION 109 0.0042
862 CHRONIC KIDNEY DISEASE 316 0.0042
863 NEUROPATHY PERIPHERAL 393 0.0041
864 NEUROTOXICITY 72 0.0041
865 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 290 0.0041
866 SWOLLEN TONGUE 127 0.0041
867 ORAL PAIN 90 0.0040
868 FEBRILE NEUTROPENIA 265 0.0040
869 ARRHYTHMIA 188 0.0040
870 ACNE 299 0.0039
871 INCORRECT PRODUCT ADMINISTRATION DURATION 85 0.0039
872 GASTROINTESTINAL HAEMORRHAGE 327 0.0039
873 THERAPEUTIC RESPONSE UNEXPECTED 175 0.0039
874 BONE DENSITY DECREASED 122 0.0039
875 INJECTION SITE ERYTHEMA 480 0.0039
876 BURNING SENSATION 271 0.0039
877 ABASIA 95 0.0038
878 HYPERSOMNIA 110 0.0038
879 VERTIGO 229 0.0038
880 INJECTION SITE URTICARIA 92 0.0037
881 PRURITUS GENERALISED 81 0.0037
882 SYNCOPE 371 0.0037
883 SNEEZING 83 0.0037
884 METABOLIC ACIDOSIS 118 0.0037
885 FLUSHING 374 0.0037
886 CARDIAC FAILURE 292 0.0036
887 UNEVALUABLE EVENT 275 0.0036
888 BLINDNESS 148 0.0036
889 HAEMATOMA 94 0.0036
890 CORONARY ARTERY DISEASE 109 0.0036
891 INJECTION SITE WARMTH 74 0.0036
892 ACUTE MYOCARDIAL INFARCTION 106 0.0036
893 DYSPHONIA 210 0.0036
894 CEREBRAL HAEMORRHAGE 127 0.0035
895 INJECTION SITE HAEMORRHAGE 283 0.0035
896 DYSARTHRIA 133 0.0035
897 MENTAL STATUS CHANGES 97 0.0035
898 HYPERHIDROSIS 449 0.0035
899 DEPRESSED MOOD 184 0.0035
900 FEELING ABNORMAL 825 0.0034
901 LIP SWELLING 114 0.0034
902 URINARY INCONTINENCE 101 0.0034
903 HOSPITALISATION 514 0.0033
904 SPEECH DISORDER 175 0.0033
905 TOXICITY TO VARIOUS AGENTS 562 0.0033
906 INJECTION SITE RASH 102 0.0033
907 EYE IRRITATION 190 0.0033
908 ATRIAL FIBRILLATION 320 0.0033
909 PNEUMONIA ASPIRATION 82 0.0033
910 EYE SWELLING 122 0.0033
911 INTERNATIONAL NORMALISED RATIO INCREASED 93 0.0033
912 TINNITUS 149 0.0032
913 OVERDOSE 698 0.0032
914 NERVOUSNESS 168 0.0032
915 TREMOR 529 0.0032
916 LOSS OF CONSCIOUSNESS 400 0.0031
917 VISION BLURRED 426 0.0031
918 SEIZURE 358 0.0031
919 PANIC ATTACK 112 0.0031
920 ANGINA PECTORIS 87 0.0030
921 INJECTION SITE SWELLING 232 0.0030
922 PRODUCT QUALITY ISSUE 410 0.0030
923 SKIN EXFOLIATION 251 0.0030
924 FEMUR FRACTURE 92 0.0030
925 HOT FLUSH 223 0.0030
926 BONE PAIN 173 0.0030
927 LACRIMATION INCREASED 89 0.0029
928 PSYCHOTIC DISORDER 87 0.0029
929 COGNITIVE DISORDER 136 0.0029
930 LUNG NEOPLASM MALIGNANT 119 0.0029
931 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 151 0.0029
932 HIP FRACTURE 93 0.0029
933 HEAD INJURY 91 0.0029
934 CARDIAC ARREST 234 0.0028
935 VISUAL ACUITY REDUCED 94 0.0028
936 POLLAKIURIA 117 0.0028
937 HYPONATRAEMIA 157 0.0028
938 HYPOGLYCAEMIA 133 0.0027
939 BRADYCARDIA 143 0.0027
940 SOMNOLENCE 538 0.0027
941 BALANCE DISORDER 229 0.0026
942 CONVULSION 149 0.0026
943 PRODUCT DOSE OMISSION ISSUE 766 0.0026
944 VAGINAL HAEMORRHAGE 112 0.0026
945 TRANSIENT ISCHAEMIC ATTACK 87 0.0026
946 BREAST CANCER 236 0.0025
947 DEPRESSED LEVEL OF CONSCIOUSNESS 98 0.0025
948 DEVICE MALFUNCTION 173 0.0025
949 CRYING 89 0.0024
950 DEVICE ISSUE 218 0.0024
951 COMA 115 0.0024
952 LACTIC ACIDOSIS 77 0.0024
953 THERAPY INTERRUPTED 168 0.0023
954 CARDIAC DISORDER 217 0.0023
955 URINARY RETENTION 77 0.0023
956 HYPOACUSIS 98 0.0023
957 MULTIPLE SCLEROSIS 106 0.0022
958 MYOCARDIAL INFARCTION 384 0.0022
959 ELECTROCARDIOGRAM QT PROLONGED 79 0.0022
960 NEUTROPHIL COUNT DECREASED 89 0.0022
961 DISORIENTATION 86 0.0022
962 CEREBROVASCULAR ACCIDENT 356 0.0021
963 DISTURBANCE IN ATTENTION 113 0.0021
964 CARDIAC FAILURE CONGESTIVE 166 0.0021
965 INTENTIONAL PRODUCT MISUSE 178 0.0020
966 DRY SKIN 269 0.0020
967 SUICIDAL IDEATION 184 0.0020
968 CARDIO-RESPIRATORY ARREST 83 0.0020
969 DRUG DOSE OMISSION 327 0.0020
970 IRRITABILITY 115 0.0019
971 DYSGEUSIA 137 0.0018
972 PRODUCT DOSE OMISSION 117 0.0018
973 THERAPY CESSATION 92 0.0018
974 AGITATION 130 0.0018
975 NO ADVERSE EVENT 310 0.0017
976 HALLUCINATION 125 0.0017
977 BLOOD GLUCOSE INCREASED 301 0.0016
978 SUICIDE ATTEMPT 94 0.0015
979 DEATH 1326 0.0015
980 PROSTATE CANCER 105 0.0013
981 MULTIPLE SCLEROSIS RELAPSE 88 0.0013
982 DRUG DEPENDENCE 205 0.0013
983 INTENTIONAL OVERDOSE 80 0.0012
984 EMOTIONAL DISTRESS 130 0.0011
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 168 0.0008